• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Model Number BLIS-X1
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Capsular Bag Tear (2639)
Date of Event 09/13/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device is not available for evaluation.The investigation is ongoing and a follow-up report will be submitted upon completion of investigation.
 
Event or Problem Description
It was reported that during the implantation of an intraocular lens (iol) into the right eye, the capsular bag collapsed when the lens was placed into the eye.The iol was removed, and a backup lens of a different model was successfully implanted.The patient outcome is good.
 
Additional Manufacturer Narrative
Although requested, the device was not returned for evaluation.A lot number was not provided; therefore a device history record (dhr) review could not be completed.The trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.Based on the information provided, a root cause could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE
Common Device Name
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
BAUSCH + LOMB
1400 goodman street
rochester NY 14609
Manufacturer (Section G)
MEDICEL AG
dornierstrasse 11
altenrhein CH ¿ 9423
SZ   CH ¿ 9423
Manufacturer Contact
shayan habibi
21 north park place blvd.
clearwater, FL 33759
7277246600
MDR Report Key18368276
Report Number0001313525-2023-70138
Device Sequence Number7806379
Product Code MSS
UDI-Device Identifier00757770520183
UDI-Public(01)00757770520183
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
K131958
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 11/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberBLIS-X1
Device Catalogue NumberBLIS-X1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date12/20/2023
Supplement Report FDA Received Date02/13/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AMVISC PLUS, ENVISTA IOL, BLIS R-1 INJECTOR
Outcome Attributed to Adverse Event Required Intervention;
Patient Age83 YR
Patient SexFemale
-
-